The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

and the US [for semaglutide]. We may not be the first wave launcher in the US, but we have plans." Natco and Mylan have also ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

It can be harder to lose weight after a certain age, which is why GLP-1 medications can be incredibly useful. That's where ...

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...

Some patients are using lower-than-recommended dosages of generic weight-loss drugs to slim down while ... and needles ...

The demand for our generic and biosimilar drugs remains stable ... Most of the market has shifted towards semaglutide and ...

Let us look at five large biotech and generic drug companies, NVO, GILD, MRNA, VTRS and TEVA, which are gearing up for their ...

Viatris is poised for appreciation with new product launches and a stronger balance sheet. Read why VTRS stock is a buy due ...

Semaglutide and liraglutide belong to the same ... There currently isn’t a generic version of either medication. (A generic drug is an exact copy of the active drug in a brand-name medication ...